drugset / Trial / NCT01803191

Efficacy Study of Prophylaxis With Fosfomycin Versus Ciprofloxacin Prior Prostate Biopsy

NCT01803191

RandomizedParallel-groupOpen-labelPrevention

Summary

The purpose of this clinical trial is compare the incidence of symptomatic or asymptomatic bacteriuria after transrectal ultrasound guided prostate biopsy using a single dose of fosfomycin 3 g one hour before the biopsy compared to observed with the use of a single dose of ciprofloxacin 500 mg 1 hour before biopsy.

Timeline

Start
2012-08
Primary completion
2016-01-25
Completion
2016-01-25

Drugs

EvaluationDrugModalityDoseRoute
Comparator Ciprofloxacin Small molecule 500 mg Oral
Subject Fosfomycin Small molecule 3 g Oral